Proteoglycan biosynthesis is required in BC3H1 myogenic cells for modulation of vascular smooth muscle alpha-actin gene expression in response to microenvironmental signals

J Cell Physiol. 1995 Jul;164(1):172-86. doi: 10.1002/jcp.1041640122.

Abstract

Induction of vascular smooth muscle (VSM) alpha-actin mRNA expression during cytodifferentiation of mouse BC3H1 myogenic cells coincides with the accumulation of cell surface- and extracellular matrix-associated sulfated proteoglycans. Inhibition of proteoglycan biosynthesis in myogenic cells using an artificial beta-D-xyloside glycosaminoglycan acceptor was accompanied by a reduction in cell surface/extracellular matrix proteoglycans and VSM alpha-actin mRNA expression while enhancing the secretion of free chondroitin sulfate/dermatan sulfate and heparan sulfate glycosaminoglycans into the culture medium. Maximum inhibition of VSM alpha-actin mRNA expression required that proteoglycan biosynthesis be blocked during the early phase of cytodifferentiation when myoblasts were fully confluent and quiescent. The inhibitory effect of beta-D-xyloside on alpha-actin mRNA expression resulted from attenuation at both the transcriptional and post-transcriptional control points. Sustained proteoglycan biosynthesis was required for induction of VSM alpha-actin mRNA in quiescent myoblasts in response to cytodifferentiation-permissive, substrate-associated macromolecules (SAM) or upon exposure to soluble serum factors capable of transiently stimulating VSM alpha-actin gene transcription. The results suggested that efficient myoblast cytodifferentiation and modulation of VSM alpha-actin mRNA levels depended on intact cell surface proteoglycans to convey signals generated as a consequence of cellular interaction with substrate components and serum factors.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Actins / genetics*
  • Animals
  • Cell Differentiation / drug effects
  • Cell Line
  • Gene Expression Regulation*
  • Glycosaminoglycans / pharmacology
  • Glycosides / pharmacology
  • Membrane Glycoproteins / metabolism
  • Mice
  • Muscle, Smooth, Vascular / metabolism*
  • Muscles / cytology
  • Muscles / metabolism*
  • Proteoglycans / biosynthesis*
  • Proteoglycans / metabolism
  • RNA, Messenger / antagonists & inhibitors
  • RNA, Messenger / metabolism
  • Signal Transduction*
  • Syndecans
  • Transcription, Genetic / drug effects

Substances

  • Actins
  • Glycosaminoglycans
  • Glycosides
  • Membrane Glycoproteins
  • Proteoglycans
  • RNA, Messenger
  • Syndecans
  • xylosides